Press Release /
Stock Exchange Intimation

Press Release / Stock Exchange Intimation

Press Release

11 Dec 2024 – Intimation regarding Allotment of Equity Shares by OneSource pursuant to the Scheme of Arrangement
29 Nov 2024 – Intimation regarding mandatory redemption of 20,000 (Twenty Thousand) secured, rated, listed, redeemable non-convertible debentures issued by the Company
27 Nov 2024 – BSE Intimation: Intimation of Effective Date for the Scheme of Arrangement amongst Strides, Steriscience and OneSource and their respective shareholders (‘Scheme’)
26 Nov 2024 – BSE Intimation: Update on the Scheme of Arrangement amongst Strides, Steriscience and OneSource
22 Nov 2024 –  Intimation under Regulation 51 – Allotment of Equity Shares via private placement basis.
19 Nov 2024 – Intimation under Regulation 51 – Receipt of NCLT approval for the Scheme of Arrangement amongst Strides Pharma Science Limited and Steriscience Specialties Private Limited and Onesource Specialty Pharma Limited and their respective shareholders.
31 Oct 2024 – Intimation under Regulation 60 – Prior Intimation of Record date for Interest payment on NCDs for November, 2024
31 Oct 2024 – Intimation under Regulation 57 – Certificate for Interest Payment For October, 2024
26 Oct 2024 – Intimation of proceedings of the Extra-Ordinary Meeting (EGM) held on Friday, October 25,2024 as per Sub-point no. 23 of Para B of Schedule III of SEBI (LODR) Regulations, 2
25 Oct 2024 – BSE Newspaper advertisement intimation for Q2 September 2024
24 Oct 2024 – Intimation of Notice of Extra-Ordinary General Meeting (EGM)
23 Oct 2024 – Appointment of Mr. Jason T Spacek as the Chief Business Officer of the Company
23 Oct 2024 – Intimation of Financial results for the half year ended September 30, 2024
23 Oct 2024 – Intimation of Statement of material deviation for the quarter ended September 30, 2024
23 Oct 2024 – Intimation of certificate under Regulation 54(2) of SEBI(LODR) Regulations, 2015 for the half year ended September 30, 2024